GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹557 Cr | ₹612 Cr | ₹699 Cr | ₹812 Cr | ₹809 Cr |
What is the latest Total Non-Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹557 Cr |
| Mar2024 | ₹612 Cr |
| Mar2023 | ₹699 Cr |
| Mar2022 | ₹812 Cr |
| Mar2021 | ₹809 Cr |
How is Total Non-Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹557 Cr | -8.92 | |
| Mar2024 | ₹612 Cr | -12.43 | |
| Mar2023 | ₹699 Cr | -13.95 | |
| Mar2022 | ₹812 Cr | 0.40 | |
| Mar2021 | ₹809 Cr | - | |
Compare Total Non-Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,386.1 Cr | 1.5% | -1.6% | 21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 5.7% | -3.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 1.6% | -7.6% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | -0.5% | 0.9% | 23.6% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.5% | -12.9% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 5.3% | -0.9% | 1.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.5% |
-1.6% |
21.8% |
| SENSEX | 1.3% |
-2.5% |
8.5% |
You may also like the below Video Courses